CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes President & CEO gave up 3,195 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Finance and Administration gave up 2,044 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President & CEO gave up 6,782 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
Page 19 of 33 · 652 filings